Published by Duncan Ferris on 26th July 2019
(Sharecast News) - Shield Therapeutics shares soared on Friday after its Feraccru/Accrufer lead product received approval from the US Food and Drug Administration.
URL: http://www.digitallook.com/dl/news/story/29354721/...